Search Results - "Hainaut, Pierre"

Refine Results
  1. 1

    A global view of hepatocellular carcinoma: trends, risk, prevention and management by Yang, Ju Dong, Hainaut, Pierre, Gores, Gregory J., Amadou, Amina, Plymoth, Amelie, Roberts, Lewis R.

    “…Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include chronic hepatitis B and…”
    Get full text
    Journal Article
  2. 2

    Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li–Fraumeni syndrome by Amadou, Amina, Waddington Achatz, Maria I, Hainaut, Pierre

    Published in Current opinion in oncology (01-01-2018)
    “…PURPOSE OF REVIEWGermline pathogenic TP53 mutation may predispose to multiple cancers but penetrance and cancer patterns remain incompletely documented. We…”
    Get full text
    Journal Article
  3. 3

    Massively regulated genes: the example of TP53 by Hollstein, Monica, Hainaut, Pierre

    Published in The Journal of pathology (01-01-2010)
    “…Intensive study of the TP53 gene over the last three decades has revealed a highly complex network of factors that regulate its performance. The gene has…”
    Get full text
    Journal Article
  4. 4

    Genetics of lung-cancer susceptibility by Brennan, Paul, Dr, Hainaut, Pierre, PhD, Boffetta, Paolo, MD

    Published in The lancet oncology (01-04-2011)
    “…Summary Lung cancer is the most common form of cancer death worldwide. Although reduction of tobacco consumption remains the most appropriate strategy to…”
    Get full text
    Journal Article
  5. 5

    Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles by Oh, Lixian, Hainaut, Pierre, Blanchet, Sandrine, Ariffin, Hany

    Published in BMC cancer (10-02-2020)
    “…TP53 mutations occur in only about 3% of primary and 10-20% of relapse B-cell precursor acute lymphoblastic leukaemia (BCP-ALL). However, alternative…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Identification of osteopontin as a novel marker for early hepatocellular carcinoma by Shang, Sufen, Plymoth, Amelie, Ge, Shaokui, Feng, Ziding, Rosen, Hugo R., Sangrajrang, Suleeporn, Hainaut, Pierre, Marrero, Jorge A., Beretta, Laura

    Published in Hepatology (Baltimore, Md.) (01-02-2012)
    “…The aim of this study was to identify a biomarker that could improve alpha‐fetoprotein (AFP) performance in hepatocellular carcinoma (HCC) surveillance among…”
    Get full text
    Journal Article
  8. 8

    Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis by Herceg, Zdenko, Hainaut, Pierre

    Published in Molecular oncology (01-06-2007)
    “…The development of cancer is driven by the accumulation of scores of alterations affecting the structure and function of the genome. Equally important in this…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance by Gormally, Emmanuelle, Caboux, Elodie, Vineis, Paolo, Hainaut, Pierre

    Published in Mutation research (01-05-2007)
    “…The presence of small amounts of tumor DNA in cell free DNA (CFDNA) circulating in the plasma or serum of cancer patients was first demonstrated 30 years ago…”
    Get full text
    Journal Article
  11. 11

    The aflatoxin-induced TP53 mutation at codon 249 ( R249S ): Biomarker of exposure, early detection and target for therapy by Gouas, Doriane, Shi, Hong, Hainaut, Pierre

    Published in Cancer letters (01-12-2009)
    “…Abstract Hepatocellular Carcinoma (HCC) in high-incidence areas (sub-Saharan Africa, South-Eastern Asia) often contains a somatic mutation at codon 249 in TP53…”
    Get full text
    Journal Article
  12. 12

    Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence by Hafsi, Hind, Hainaut, Pierre

    Published in Antioxidants & redox signaling (15-09-2011)
    “…The p53 tumor suppressor protein has achieved stardom in molecular oncology owing to frequent inactivation in a large range of cancers. Known as a factor…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain by Lambert, Jeremy M.R., Gorzov, Petr, Veprintsev, Dimitry B., Söderqvist, Maja, Segerbäck, Dan, Bergman, Jan, Fersht, Alan R., Hainaut, Pierre, Wiman, Klas G., Bykov, Vladimir J.N.

    Published in Cancer cell (05-05-2009)
    “…Restoration of wild-type p53 expression triggers cell death and eliminates tumors in vivo. The identification of mutant p53-reactivating small molecules such…”
    Get full text
    Journal Article
  16. 16

    Role of Obesity in the Risk of Breast Cancer: Lessons from Anthropometry by Amadou, Amina, Hainaut, Pierre, Romieu, Isabelle

    Published in Journal of Oncology (01-01-2013)
    “…An estimated 1.38 million new cases of breast cancer (BC) are diagnosed each year in women worldwide. Of these, the majority are categorized as invasive ductal…”
    Get full text
    Journal Article
  17. 17

    Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells by Vincent, Isabelle E, Zannetti, Claudia, Lucifora, Julie, Norder, Helene, Protzer, Ulrike, Hainaut, Pierre, Zoulim, Fabien, Tommasino, Massimo, Trépo, Christian, Hasan, Uzma, Chemin, Isabelle

    Published in PloS one (25-10-2011)
    “…Plasmacytoid dendritic cells (pDCs) play a key role in detecting pathogens by producing large amounts of type I interferon (IFN) by sensing the presence of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer by Reynoird, Nicolas, Mazur, Pawel K, Stellfeld, Timo, Flores, Natasha M, Lofgren, Shane M, Carlson, Scott M, Brambilla, Elisabeth, Hainaut, Pierre, Kaznowska, Ewa B, Arrowsmith, Cheryl H, Khatri, Purvesh, Stresemann, Carlo, Gozani, Or, Sage, Julien

    Published in Genes & development (01-04-2016)
    “…Pancreatic ductal adenocarcinoma (PDAC) is a lethal form of cancer with few therapeutic options. We found that levels of the lysine methyltransferase SMYD2…”
    Get full text
    Journal Article
  20. 20

    Roles of thioredoxin reductase 1 and APE Ref-1 in the control of basal p53 stability and activity by SEEMANN, Séverine, HAINAUT, Pierre

    Published in Oncogene (02-06-2005)
    “…The p53 protein is redox-sensitive in vitro but in vivo effectors of this sensitivity are not known. In yeasts deficient for thioredoxin (Trx) reductase (TRR),…”
    Get full text
    Journal Article